United Services Automobile Association Argenx Se Transaction History

United Services Automobile Association

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$113.31 - $150.51 $6.08 Million - $8.07 Million	-53,650 Closed	0 $0
Q2 2019 Aug 16, 2019	BUY	$115.0 - $141.58 $718,750 - $884,875	6,250 Added 13.19%	53,650 $7.6 Million
Q1 2019 May 13, 2019	SELL	$98.85 - $134.59 $1.59 Million - $2.17 Million	-16,100 Reduced 25.35%	47,400 $5.92 Million
Q4 2018 Feb 13, 2019	BUY	$63.81 - $109.82 $172,287 - $296,514	2,700 Added 4.44%	63,500 $6.1 Million
Q3 2018 Nov 13, 2018	BUY	$75.5 - $96.63 $2.16 Million - $2.76 Million	28,600 Added 88.82%	60,800 $4.61 Million
Q2 2018 Sep 27, 2018	SELL	$74.84 - $100.16 $2.06 Million - $2.75 Million	-27,468 Reduced 46.03%	32,200 $2.67 Million
Q2 2018 Aug 10, 2018	BUY	$74.84 - $100.16 $3.12 Million - $4.17 Million	41,668 Added 231.49%	59,668 $280,000
Q1 2018 May 14, 2018	SELL	$56.95 - $85.19 $466,990 - $698,558	-8,200 Reduced 31.3%	18,000 $1.45 Million
Q4 2017 Feb 14, 2018	BUY	$22.57 - $63.56 $591,334 - $1.67 Million	26,200	26,200 $1.65 Million

432

29.2M

390K

272K

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $35.7B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.